(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PREPARAÇÃO FARMACÊUTICA QUE COMPREENDE CLOPIDOGREL PARA USO NO TRATAMENTO DE GLOMERULOESCLEROSE SEGMENTAR FOCAL (GESF)

Em AnáliseInvention PatentPCT · EP2021084250

Application data

Number

112023010277

Type

Invention Patent

Filing

12/03/2021

Publication

06/27/2023

PCT

EP2021084250

Progress at the INPI

  1. Filing12/03/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 12/03/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/27/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

DELTA 4 GMBH

AT

Inventors

P. P. (pessoa física)

AT

Technical data

Priority claims

EP

20211546.5 · 12/03/2020

Abstract

PREPARAÇÃO FARMACÊUTICA QUE COMPREENDE CLOPIDOGREL PARA USO NO TRATAMENTO DE GLOMERULOESCLEROSE SEGMENTAR FOCAL (GESF).A presente invenção refere-se a uma preparação farmacêutica que compreende clopidogrel ou um de seus sais ou solvatos, para uso no tratamento de glomeruloesclerose segmentar focal (GESF).

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

06/27/2023

RPI 2738

Alteração de dados cadastrais

#1.1

06/06/2023

RPI 2735

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.